315 results
Page 2 of 16
8-K
EX-99.1
wclnz3mc3
13 Sep 22
Alnylam Announces Proposed Offering of $900 Million Convertible Senior Notes
4:05pm
8-K
EX-99.1
ew1vfg51csf0htn04cwq
28 Jul 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
csndi33
14 Jun 22
Other Events
7:30am
8-K
EX-99.1
02h9sho61 tbxvw
28 Apr 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
6l70i6qh2jcxzfjr
5 Apr 22
Alnylam Announces Retirement of Steven Paul, M.D. from Board of Directors
4:16pm
8-K
EX-99.1
e45 s03iu
4 Apr 22
Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran
7:35am
8-K
EX-99.1
nl1fs
10 Feb 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
61e7tj8bz wj4o
10 Jan 22
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates
7:01am
8-K
EX-99.1
42jx6wyken6yawe616
4 Jan 22
Alnylam Announces Promotion of Dr. Akshay Vaishnaw to President
4:16pm
8-K
EX-99.2
d4e5e50u42iw np9ts
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am
8-K
EX-99.1
jfu24q 4qjr1
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am